preface

BDO Israel
DOING BUSINESS IN ISRAEL
Capital Raised by Israeli Life Science Companies ($M), 2004-2010
88 86
0 0
A major sub-branch of biotechnology is the medical device field. This sector in
2010 drew 62% of the aggregate capital raised for the industry - marking a 4%
decline of its share compared with the previous year. A notable increase in
2010 occurred in the pharmaceuticals sub-sector, responsible for 31% of the
total capital raised for the sector, compared with 13% in 2009.
The Israeli government has encouraged investments in this sector, by initiating
plans to establish incubators dedicated to bio-technological development.
The following graphs show the capital raised by the Israeli life science industry
and the dominance of medical device companies vis-a-vis other sectors over
the past three years:
Capital Raised by Israeli Life Science Companies (%), 2008-2010
4% 8%
8%
3%
6%
96
The following graph shows the capital raised by the Israeli life science industry
divided into sub-sectors over the past ten years:
80
80
60
40
20
29